All Thayer Events

Jones Seminar: Transforming the Future of Cancer Care with Optical Imaging

Jan

24

Friday
3:30pm - 4:30pm ET

Spanos Auditorium/Online

Optional ZOOM LINK
Meeting ID: 962 3557 9087
Passcode: 651327

Optical imaging systems play a crucial role in clinical care, enhancing vision and providing essential insights for diagnosis, treatment, and monitoring. The future of this technology lies in real-time, minimally invasive diagnostics and treatment guidance. Building on advancements from the Optics in Medicine lab at Thayer, this talk will introduce recent innovations in optical cancer detection and therapy guidance in radiotherapy and surgical cancer care, with a focus on the path toward initial clinical trials. Through first-hand real-world examples, we will explore how innovative biochemical and physical principles can be translated into practical, reliable devices for complex healthcare settings. This presentation aims to inspire new perspectives on engineering optical sensors and integrated systems to meet critical clinical needs and enable novel therapies.

Hosted by Professor Scott Davis.

About the Speaker(s)

Petr Brůža
Assistant Professor of Engineering, Dartmouth

Petr Bruza

Petr Brůža is an assistant professor of engineering at Dartmouth, specializing in advanced imaging solutions to improve outcomes in radiotherapy and surgical guidance. He also holds adjunct faculty appointments at the University of Wisconsin-Madison and the Dartmouth Cancer Center. He earned his PhD in biomedical engineering from Czech Technical University and completed postdoctoral training at the Czech Academy of Sciences, with research internships at Brown University and Stanford University. A member of The Optical Society of America and the American Association of Physicists in Medicine, Brůža also serves as an associate editor of Medical Physics and guest editor of BMC Medical Imaging. Beyond academia, he leads technology research and development in startup companies, including DoseOptics LLC, where his hardware recently received FDA clearance and is now being deployed clinically.

Contact

For more information, contact Ashley Parker at ashley.l.parker@dartmouth.edu.